✦ LIBER ✦

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

✍ Scribed by Eric J. Gowans; Stuart Roberts; Kathryn Jones; Irene Dinatale; Philippe A. Latour; Brendan Chua; Emily M.Y. Eriksson; Ruth Chin; Shuo Li; Dominic M. Wall; Rosemary L. Sparrow; Jude Moloney; Maureen Loudovaris; Rosemary Ffrench; H. Miles Prince; Derek Hart; Weng Zeng; Joseph Torresi; Lorena E. Brown; David C. Jackson

Book ID: 116652203
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 774 KB
Volume: 53
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.05.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A518 Dendritic Cells Immunotherapy: A Ph

A518 Dendritic Cells Immunotherapy: A Phase II Clinical Trial

✍ Zahradova, L; Stejskalova, A; Novotna, H; Jelinkova, I; Penka, M; Hajek, R; Ocad 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 102 KB

Immunogenicity of CIGB-230, a therapeuti

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

✍ L. Alvarez-Lajonchere; N. H. Shoukry; B. Grá; Y. Amador-Cañizares; F. Helle; N. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Durable complete clinical responses in a

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

✍ Michael G. E. O'Rourke; Maree Johnson; Catherine Lanagan; Janet See; Jie Yang; J 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

C156 Dendritic cell-based immunotherapy

C156 Dendritic cell-based immunotherapy in patients with rising PSA after radical prostatectomy or salvage radiotherapy (phase I/II clinical trials)

✍ Jarolim, L.; Spíšek, R.; Podrazil, M.; Babjuk, M.; Fučíková, J.; Fialová, A.; Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Clinical Evaluation of Dendritic Cell Va

Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial

✍ Yamanaka, R. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 689 KB

Evaluation of phase I/II clinical trials

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

✍ Tjoa, B.A.; Simmons, S.J.; Bowes, V.A.; Ragde, H.; Rogers, M.; Elgamal, A.; Kenn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Background: A phase i trial involving patients with advanced prostate cancer was conducted to assess the safe administration of dendritic cells (dc) and hla-a0201-specific prostate-specific membrane antigen (psma) peptides (psm-p1 or -p2). thirty-three of the phase i participants were subsequent